Seroba Life Sciences is a European venture capital firm that focuses on early and mid-stage life sciences companies, primarily investing in cutting-edge biotech and medtech innovations across Europe and selectively in North America. Their strategy involves backing "winning innovations" that address unmet medical needs, improve health outcomes, and offer significant return potential, often taking a lead or co-lead investment role and integrating ESG criteria for positive societal impact.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-d (50% of deals).
Portfolio
2
Fund Size
$123M
Top Stage
Series D
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Shorla Pharma Limited | Series A | $8.3M | Jun 2020 |
 Endotronix, Inc. | Series D | $45M | Sep 2018 |
Top Co-Investors
LSP1 shared
Aperture Venture Partners1 shared
SV Health Investors1 shared
Wanxiang Healthcare1 shared
Enterprise Ireland1 shared
Last updated: 28 April 2026